ReviewThe AAPS journal2022
Evaluation of Excipient Risk in BCS Class I and III Biowaivers.
Melissa Metry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewThe AAPS journal2022
Melissa Metry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.